You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lower risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Lower-risk Myelodysplastic Syndrome Trial in Tampa (JSP191)

Recruiting
  • Lower-risk Myelodysplastic Syndrome
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2023

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

Lower-risk MDS Patients

Recruiting
  • MDS
    • Leipzig, Germany
      University Hospital Leipzig
    Oct 13, 2022

    MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

    Recruiting
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Darbepoetin Alfa
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 21, 2022

    Breast Cancer Trial in Ottawa (No endocrine therapy, Endocrine therapy)

    Recruiting
    • Breast Cancer
    • No endocrine therapy
    • Endocrine therapy
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Sep 13, 2022

    MDS Trial (Hetrombopag)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    May 23, 2022

    Low Risk MDS Trial (R906289 Monosodium (R289 Na))

    Not yet recruiting
    • Low Risk Myelodysplastic Syndromes
    • R906289 Monosodium (R289 Na)
    • (no location specified)
    Jul 22, 2022

    Hydroxychloroquine May be Beneficial for Preeclampsia

    Not yet recruiting
    • Pre-Eclampsia
    • (no location specified)
    Aug 27, 2023

    MDS Trial (AG-946, Placebo)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    Aug 4, 2022

    Lower-risk Myelodysplastic Trial in Tokyo (ASTX727)

    Active, not recruiting
    • Lower-risk Myelodysplastic
    • Tokyo, Japan
      NTT Medical Center Tokyo
    Jan 14, 2022

    MDS Trial in United States (Lenalidomide, Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Miami, Florida
    • +5 more
    Sep 28, 2022

    Total Hip Replacement Trial (postoperative rehabilitation)

    Completed
    • Total Hip Replacement
    • postoperative rehabilitation
    • (no location specified)
    Oct 4, 2023

    MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

    Recruiting
    • Myelodysplastic Syndromes
    • Duarte, California
    • +14 more
    Jan 23, 2023

    Cigarette Smoking Trial in Los Angeles (NIDA Standard Research E-cigarette (SREC))

    Not yet recruiting
    • Cigarette Smoking
    • NIDA Standard Research E-cigarette (SREC)
    • Los Angeles, California
      University of Southern California, Health Sciences Campus
    Dec 1, 2021

    Elderly Subjects, Risk of Fall Trial in Ancona (DigiPrehab system)

    Recruiting
    • Elderly Subjects
    • Risk of Fall
    • DigiPrehab system
    • Ancona, Italy
      IRCCS INRCA Hospital
    Apr 27, 2023

    Postsurgical Pain After Open Reduction and Internal Fixation of

    Enrolling by invitation
    • Chronic Post Operative Pain
      • Xuzhou, Jiangsu, China
        Xuzhou Central Hospital
      Nov 14, 2023

      Lower Incisors and Associated Risk Factors :Cross-sectional

      Recruiting
      • Gingival Diseases
        • Nice, France
          University Hospital of Nice
        Apr 14, 2023

        MDS Trial in Germany (Luspatercept)

        Recruiting
        • Myelodysplastic Syndromes
        • Hamburg, Germany
        • +4 more
        Dec 20, 2021

        MDS Trial in Japan (Eltrombopag, Placebo)

        Recruiting
        • Myelodysplastic Syndromes
        • Narita, Chiba, Japan
        • +21 more
        Jan 19, 2023

        Endovascular Revascularization in Lower Extremity

        Recruiting
        • Peripheral Arterial Occlusive Disease
        • endovascular revascularization
        • Xian, Shaanxi, China
          First Affiliated Hospital of Xi 'an Jiaotong University
        Oct 20, 2022

        Venous Thrombosis of Lower Limbs After Hospitalization in

        Recruiting
        • Patients Hospitalized for More Than 48 Hours for Acute Medical Illness
          • Monastir, Tunisia
            Nouira
          Aug 22, 2022

          Eating Behavior Trial in Montréal (Education - Motivational factor)

          Recruiting
          • Eating Behavior
          • Education - Motivational factor
          • Montréal, Quebec, Canada
            McGill University
          Jan 24, 2023